Feasibility and Outcomes of Complete Coronary Revascularization Using BVS in All-comer Patients With Angina

CompletedOBSERVATIONAL
Enrollment

1,602

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

June 30, 2017

Study Completion Date

July 31, 2018

Conditions
Angina
Interventions
DEVICE

Bioresorbable vascular scaffold (BVS) implantation

Trial Locations (14)

121352

Clinical Hospital No 1 of Department of Presidents Affairs, Moscow

121359

President's Hospital with Policlinic, Moscow

129128

Central Railway Hospital 2, Moscow

454003

Federal Center for Cardiovascular Surgery, Chelyabinsk

650002

Federal State Budgetary Scientific Institution Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo

Unknown

Federal Cardiovascular Center, Krasnoyarsk

Regional Clinical Hospital, Krasnoyarsk

CELT Hospital, Moscow

City Clinical Hospital named S.S.Yudina Department of Health of the City of Moscow, Moscow

Tyumen Cardiology Center, Tyumen

685 000

Regional Hospital, Magadan

350 086

Regional Clinical Hospital n.a. S.V., Krasnodar

238 312

Federal Cardiovascular Center, Kaliningrad

614 013

Federal Cardiovascular Center, Perm

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

KCRI

OTHER

lead

International Foundation for Development of Medical Science and Education Healthy Heart

OTHER

NCT02707783 - Feasibility and Outcomes of Complete Coronary Revascularization Using BVS in All-comer Patients With Angina | Biotech Hunter | Biotech Hunter